Pacilitaxel,USP27, Min 99%, white powder
MF：C47H51NO14，
MW：853.90
Cas No. 33069-62-4
Source: Taxus media,etc
1: Son MJ, Song HS, Kim MH, Kim JT, Kang CM, Jeon JW, Park SY, Kim YJ, Groves MD, Park K, Kim JH, Nam DH.
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
Int J Oncol. 2006 Jun;28(6):1385-92.
2: Tsunezuka Y, Oda M, Moriyama
H. [A Case of a Second Cancer of Metachronous Multiple Primary Non-Small Cell Lung Cancer Successfully Treated with TS-1 and CDDP Chemotherapy.]
Gan To Kagaku Ryoho. 2006 May;33(5):651-3. Japanese.
3: Kii T, Takiuchi H, Gotoh M, Kawabe S, Ohta S, Tanaka T, Kuwakado S, Nishitani H, Katsu K.
[Weekly Administration Regimen of Paclitaxel(PTX) in Patient with Inoperable or Recurrent Gastric Cancer.]
Gan To Kagaku Ryoho. 2006 May;33(5):621-4. Japanese.
4: Sutani A, Kobayashi K. [Lung carcinoma.]
Gan To Kagaku Ryoho. 2006 May;33(5):590-4. Japanese.
PMID: 16685153 [PubMed - in process]
5: Wong AS, Soo RA, Lu JJ, Loh KS, Tan KS, Hsieh WS, Shakespeare TP, Chua ET, Lim HL, Goh BC. Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma.
Ann Oncol. 2006 May 9; [Epub ahead of print]
|
|
|
|
|
